Biodexa Pharmaceuticals (BDRX)

• Market cap: $1.97M
• 1 day: 1.73%
• 5 days: -7.84%
• 1 month: -42.26%
• 3 months: -78.44%
• 6 months: -73.2%
• Year to date: -4.47%
• 1 year: -94.8%
• 5 years: -100%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Employees: 13